New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review.
COVID-19
COVID-19 vaccine
neuromyelitis optica
outcomes
severe acute respiratory syndrome coronavirus 2
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
11
2022
accepted:
26
05
2023
medline:
10
7
2023
pubmed:
10
7
2023
entrez:
10
7
2023
Statut:
epublish
Résumé
Neuromyelitis optica spectrum disorder (NMOSD) is a rare chronic neuroinflammatory autoimmune condition. Since the onset of the COVID-19 pandemic, there have been reports of NMOSD clinical manifestations following both SARS-CoV-2 infections and COVID-19 vaccinations. This study aims to systematically review the published literature of NMOSD clinical manifestations associated with SARS-CoV-2 infections and COVID-19 vaccinations. A Boolean search of the medical literature was conducted between December 1, 2019 to September 1, 2022, utilizing Medline, Cochrane Library, Embase, Trip Database, Clinicaltrials.gov, Scopus, and Web of Science databases. Articles were collated and managed on Covidence A total of 702 articles were imported for screening. After removing 352 duplicates and 313 articles based on exclusion criteria, 34 articles were analyzed. A total of 41 cases were selected, including 15 patients that developed new onset NMOSD following a SARS-CoV-2 infection, 21 patients that developed This systematic review suggests that there is an association between NMOSD and SARS-CoV-2 infections and COVID-19 vaccinations. This association requires further study using quantitative epidemiological assessments in a large population to better quantify the risk.
Sections du résumé
Background
UNASSIGNED
Neuromyelitis optica spectrum disorder (NMOSD) is a rare chronic neuroinflammatory autoimmune condition. Since the onset of the COVID-19 pandemic, there have been reports of NMOSD clinical manifestations following both SARS-CoV-2 infections and COVID-19 vaccinations.
Objective
UNASSIGNED
This study aims to systematically review the published literature of NMOSD clinical manifestations associated with SARS-CoV-2 infections and COVID-19 vaccinations.
Methods
UNASSIGNED
A Boolean search of the medical literature was conducted between December 1, 2019 to September 1, 2022, utilizing Medline, Cochrane Library, Embase, Trip Database, Clinicaltrials.gov, Scopus, and Web of Science databases. Articles were collated and managed on Covidence
Results
UNASSIGNED
A total of 702 articles were imported for screening. After removing 352 duplicates and 313 articles based on exclusion criteria, 34 articles were analyzed. A total of 41 cases were selected, including 15 patients that developed new onset NMOSD following a SARS-CoV-2 infection, 21 patients that developed
Conclusion
UNASSIGNED
This systematic review suggests that there is an association between NMOSD and SARS-CoV-2 infections and COVID-19 vaccinations. This association requires further study using quantitative epidemiological assessments in a large population to better quantify the risk.
Identifiants
pubmed: 37426444
doi: 10.3389/fneur.2023.1099758
pmc: PMC10323143
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
1099758Informations de copyright
Copyright © 2023 Harel, Gorman and Wallin.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Radiol Case Rep. 2021 Dec;16(12):3864-3867
pubmed: 34659602
JAMA Neurol. 2014 Dec;71(12):1506-13
pubmed: 25329096
Mult Scler Relat Disord. 2022 Dec;68:104141
pubmed: 36037757
Vaccines (Basel). 2022 Jun 27;10(7):
pubmed: 35891192
Indian J Ophthalmol. 2022 May;70(5):1828-1831
pubmed: 35502086
SN Compr Clin Med. 2022;4(1):130
pubmed: 35761845
Mult Scler Relat Disord. 2022 Jan;57:103321
pubmed: 35158439
QJM. 2021 Nov 5;114(8):591-593
pubmed: 33787891
J Neuroimmunol. 2022 Jan 15;362:577765
pubmed: 34839149
Nat Med. 2022 Jan;28(1):20-23
pubmed: 35039657
J Coll Physicians Surg Pak. 2021 Jul;31(7):138-140
pubmed: 34271816
J Neurol. 2021 Apr;268(4):1171-1178
pubmed: 32852580
J Korean Med Sci. 2021 Aug 09;36(31):e228
pubmed: 34402238
Mult Scler Relat Disord. 2022 Apr;60:103697
pubmed: 35306242
J Neurol Sci. 2011 Jan 15;300(1-2):19-22
pubmed: 21056429
Int J Neurosci. 2022 Oct;132(10):999-1004
pubmed: 33280477
Lancet. 2003 Nov 15;362(9396):1659-66
pubmed: 14630450
Vaccines (Basel). 2021 Dec 30;10(1):
pubmed: 35062704
Neuroradiology. 2022 Oct;64(10):2085-2089
pubmed: 35809100
Neurol Sci. 2021 Sep;42(9):3537-3539
pubmed: 34189662
BMJ Med. 2022 Apr 1;1(1):e000040
pubmed: 36936563
Viruses. 2019 Dec 20;12(1):
pubmed: 31861926
J Neurol. 2022 Jun;269(6):2850-2853
pubmed: 35064812
Mult Scler Relat Disord. 2022 Oct;66:104035
pubmed: 35858498
Mult Scler Relat Disord. 2022 Feb;58:103424
pubmed: 35216793
Mult Scler Relat Disord. 2022 Oct;66:104055
pubmed: 35843141
Br J Hosp Med (Lond). 2020 Sep 2;81(9):1-3
pubmed: 32990089
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
J Neurol Sci. 2015 Nov 15;358(1-2):520-1
pubmed: 26440423
Cureus. 2021 Sep 14;13(9):e17961
pubmed: 34660149
Neurologist. 2022 May 01;27(3):147-150
pubmed: 35184119
Psychoneuroendocrinology. 2021 Sep;131:105295
pubmed: 34119855
J Autoimmun. 2010 Jun;34(4):371-9
pubmed: 19853412
Acta Neurol Belg. 2021 Aug;121(4):859-866
pubmed: 33934300
Mult Scler Relat Disord. 2019 Jan;27:289-293
pubmed: 30448469
J Virol. 2020 Mar 17;94(7):
pubmed: 31996437
Biomedicines. 2019 Jun 12;7(2):
pubmed: 31212763
J Clin Neurosci. 2018 Jan;47:14-19
pubmed: 29066232
Clin Case Rep. 2021 Jun 10;9(6):e04347
pubmed: 34136250
J Neurol. 2022 Jan;269(1):55-58
pubmed: 34115170
Autoimmun Rev. 2014 Mar;13(3):215-24
pubmed: 24514081
J Neurol. 2022 Oct;269(10):5213-5215
pubmed: 35731277
J Pediatr. 2022 Aug;247:22-28.e2
pubmed: 35577119
J Neurol. 2022 Jan;269(1):49-54
pubmed: 34131771
J Neurol. 2022 Feb;269(2):541-576
pubmed: 34386902
Cureus. 2022 Mar 22;14(3):e23405
pubmed: 35475081
J Neuroimmunol. 2021 Apr 15;353:577523
pubmed: 33640717
J Neuroimmunol. 2022 Oct 15;371:577939
pubmed: 35939945
Ocul Immunol Inflamm. 2022 Jul 18;:1-3
pubmed: 35849732
J Neurol. 2022 Mar;269(3):1093-1106
pubmed: 34480607
Immunity. 2020 May 19;52(5):731-733
pubmed: 32325025
Neurol Int. 2021 Mar 09;13(1):102-119
pubmed: 33803475
Cureus. 2020 Apr 29;12(4):e7889
pubmed: 32489743
Front Immunol. 2021 Apr 26;12:653786
pubmed: 33981305
J Clin Neurol. 2017 Jul;13(3):227-233
pubmed: 28748673
Front Neurol. 2022 Feb 24;13:796882
pubmed: 35280277
Neurology. 2021 Jan 12;96(2):59-77
pubmed: 33310876
J Neuroimmunol. 2020 Nov 11;350:577439
pubmed: 33333471
Case Rep Neurol Med. 2020 Dec 28;2020:6682251
pubmed: 33425411
Mult Scler Relat Disord. 2022 Feb;58:103414
pubmed: 35216789
Indian J Ophthalmol. 2022 May;70(5):1833-1836
pubmed: 35502088
BMC Neurol. 2022 May 18;22(1):185
pubmed: 35585528
Mult Scler. 2021 May;27(6):973-976
pubmed: 32909895
Am J Respir Crit Care Med. 2019 Jun 15;199(12):1517-1536
pubmed: 30554520